The Dilemma in COVID-19 Pandemic: The Protection of Intellectual Property Rights or A Life?
Downloads
Abstract
Access to medicines and health facilities is a form of fulfillment of the right to health which, if not fulfilled, will result in the loss of the right to life. During the time of COVID-19 that hit the whole world, data released by WHO stated that 4,592,934 people had died from COVID-19, and the number was growing globally every day. However, only 5,352,927,296 doses of vaccines have been administered worldwide, with most going to developed countries. Experts predict the global population will be fully vaccinated by at least September 2023. WHO research shows that through vaccination, the rate of transmission of the disease can be reduced, and even if the subject is infected, vaccination can still reduce mortality and severity. However, its manufacture and distribution are protected by several intellectual property rights (IPR) legal instruments, which have resulted in several Global South countries, especially Indonesia being late in the vaccination process. This article aims to criticize how vaccine distribution is hampered due to regulations related to IPR, namely patents and trade secret. The author uses normative juridical research methods to answer the problems in this study by focusing on literature research and secondary data related to vaccination and the right to health which have implications for the right to human life. Comparison with other countries, especially South Africa fighting HIV/AIDS for years using the flexibilities of TRIPs, is also the subject of this research. This research describes how the Global North countries have a significant role in distributing the COVID-19 vaccine to the Global South. The delay in allotment due to regulations related to Intellectual Property Rights causes violations of several fundamental rights.
Keywords: Bankruptcy; Insolvency Test; Principle of Balance.
Books
Carlos Correa, Integrating Public Health Concerns into Patent Legislation in Developing Countries (South Centre 2000).
Christian Tomuschat, Human Rights : Between Idealism and Realism (Oxford University Press 2008).
Gary Gereffi, The Pharmaceutical Industry and Dependency in the Third World (Princeton University Press 1983).
H.S. Kartadjoemana, GATT WTO Dan Hasil Uruguay Round (UI Press 2007).
Journals
Anna Lanoszka, ‘The Global Politics of Intellectual Property Rights and Pharmaceutical Drug Policies in Developing Countries' (2003) 24 International Political Science Review.
Anthony McDonnell and et.al, ‘COVID-19 Vaccine Predictions: Using Mathematical Modelling and Expert Opinions to Estimate Timelines and Probabilities of Success of COVID-19 Vaccines' (2020) 183 CGD Policy Paper <https://www.hrw.org/news/2021/05/06/covax-enhance-transparency-share-intellectual-property>.
James J. Wheaton, ‘Generic Competition and Pharmaceutical Innovation: The Drug Price Competition and Patent Term Restoration Act of 1984' (1986) 35 Catholic University Law Review.
Kirsten Peterson, ‘Recent Intellectual Property Trends in Developing Countries' (1992) 33 Harvard International Law Journal.
Nadia Natasha Seeretan, ‘The Negative Impact of Intellectual Property Patent Rights on Developing Countries: An Examination of the Indian Pharmaceutical Industry' (2017) 3 St. Mary's Law Review on Race and Social Justice.
Naomi A. Bass, ‘Implications of the Trips Agreement for Developing Countries: Pharmaceutical Patent Laws in Brazil and South Africa in the 21st Century' (2002) 34 The George Washington International Law Review.
Rasche Andreas and Sandra Waddock, ‘The UN Guiding Principles on Business and Human Rights: Implications for Corporate Social Responsibility Research' (2021) 6 Business and Human Rights Journal 227.
T. Walley, ‘Monitoring Financial Flows for Health Research Geneva: Global Forum for Health Research' (2002) 96 Transactions of The Royal Society of Tropical Medicine and Hygiene.
Tshimanga Kongolo, ‘Public Interest versus the Pharmaceutical Industry's Monopoly in South Africa' (2001) 4 Journal of World Intellectual Property.
Hearing, Report, and Working Papers
Carlos Correa, ‘Implications of the Doha Declaration on the TRIPS Agreement and Public Health' (2002) WHO/EDM/PAR/2002.
Economic and Social Council, ‘Statement on the Coronavirus Disease (COVID-19) Pandemic and Economic, Social and Cultural Rights' (2020).
Immunization; Vaccines; and Biological Team of World Health Organization, ‘Evaluation of COVID-19 Vaccine Effectiveness' (2021) WHO/2019-nCoV/vaccine_effectiveness/measurement/2021.
Mohamed Omar Gad, ‘TRIPS Dispute Settlement and Developing Country Interests' (2008).
World Health Organization, ‘The World Medicines Situation 2nd Ed' (2004) WHO/EDM/PAR/2004.
World Trade Organization, ‘Waiver From Certain Provisions of The TRIPS Agreement For The Prevention, Containment and Treatment of COVID-19' (2021).
Case
The High Court of South Africa, Pharmaceutical company lawsuit (forty-two applicants) against the Government of South Africa (ten respondents), 1998.
Laman
Badan Pusat Statistik, ‘Hasil Sensus Penduduk 2020' (Badan Pusat Statistik, 2021) <https://www.bps.go.id/pressrelease/2021/01/21/1854/hasil-sensus-penduduk-2020.html> accessed 31 October 2021.
Human Rights Watch, ‘Urgently Waive Intellectual Property Rules for Vaccine' (Human Rights Watch, 2020) <https://www.hrw.org/news/2020/12/10/urgently-waive-intellectual-property-rules-vaccine> accessed 28 May 2021.
””, ‘COVAX: Enhance Transparency, Share Intellectual Property' (Human Rights Watch, 2021).
””, ‘Seven Reasons the EU Is Wrong to Oppose the TRIPS Waiver' (2021) <https://www.hrw.org/news/2021/06/03/seven-reasons-eu-wrong-oppose-trips-waiver> accessed 3 June 2021.
Josh Holder, ‘Tracking Coronavirus Vaccinations Around the World' (The New York Times, 2022) <https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html> accessed 5 November 2021.
OHCHR, ‘What Are Human Rights?' (United Nations Human Rights) <https://www.ohchr.org/en/issues/pages/whatarehumanrights.aspx> accessed 17 December 2020.
Robert Bollinger, Stuart Ray, and Lisa Maragakis, ‘COVID Variants: What You Should Know' (Johns Hopkins Medicine, 2021) <https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/a-new-strain-of-coronavirus-what-you-should-know> accessed 28 May 2021.
Sara M. Allinder and Janet Fleischman, ‘The World's Largest HIV Epidemic in Crisis: HIV in South Africa' (Center for Strategic & International Studies (CSIS), 2019) <https://www.csis.org/analysis/worlds-largest-hiv-epidemic-crisis-hiv-south-africa> accessed 28 June 2021.
Satuan Tugas Penanganan COVID-19, ‘Beranda' (Covid-19.go.id, 2020).
Soutik Biswas, ‘Mucormycosis: The ‘black Fungus' Maiming Covid Patients in India' (BBC, 2021) <https://www.bbc.com/news/world-asia-india-57027829> accessed 9 May 2021.
Steve Cockburn, ‘WTO: A Missed Opportunity to Put People before Patents' (Amnesty, 2020) <https://www.amnesty.org/en/latest/news/2020/10/wto-states-waiver-trade-rules-for-covid19-vaccine/> accessed 30 June 2021.
William J. Clinton, ‘Executive Order 13155”Access to HIV/AIDS Pharmaceuticals and MedicalTechnologies' (The American Presidency Project, 2000) <https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/a-new-strain-of-coronavirus-what-you-should-know> accessed 28 May 2021.
World Health Organization, ‘WHO Coronavirus (COVID-19) Dashboard' (World Health Organization, 2020) <https://covid19.who.int/> accessed 28 May 2021.
””, ‘Waive Covid Vaccine Patents to Put World on War Footing' (World Health Organization, 2021) <https://www.who.int/news-room/commentaries/detail/waive-covid-vaccine-patents-to-put-world-on-war-footing> accessed 6 June 2021.
Regulations
South African Medicines and Medical Devices Regulatory Authority Act, Medicines and Related Substances Control Amendment Act 1997.
Agreement on Trade-Related Aspects of Intellectual Property Rights as Amended by the 2005 Protocol Amending the TRIPS Agreement.
Declaration on the TRIPs Agreement and Public Health 2001.
Copyright (c) 2022 Debby Kristin, Chloryne Trie Isyana Dewi
This work is licensed under a Creative Commons Attribution 4.0 International License.
